• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    68.27 -8.29 (-10.83%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna, Inc. - Common Stock

    < Previous 1 2
    ...
    18 19 20 21 22 23 24 25 26
    ...
    99 100 Next >
    News headline image
    Which S&P500 stocks are gapping on Monday? ↗
    Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
    Via Chartmill
    News headline image
    FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up ↗
    The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine. 
    Via Benzinga
    News headline image
    Moderna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-Up ↗
    The company plans to make mRESVIA available for both younger and older adults in the U.S. ahead of the 2025-2026 respiratory virus season. 
    Via Stocktwits
    Topics Government
    News headline image
    3 Healthcare Stocks with Questionable Fundamentals
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
    Via StockStory
    Topics Stocks
    News headline image
    Down 80%, Should You Buy the Dip on Moderna? ↗
    Via The Motley Fool
    News headline image
    Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
    Via ACCESS Newswire
    News headline image
    Exploring the top movers within the S&P500 index during today's session. ↗
    Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
    Via Chartmill
    News headline image
    Is it Time to Dump Your Shares of Moderna? ↗
    Via The Motley Fool
    News headline image
    RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report ↗
    Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices. 
    Via Benzinga
    News headline image
    CDC Reinstates 450 Workers After Layoffs Spark Public Health Concerns: Report ↗
    The U.S. Centers for Disease Control and Prevention reversed course Wednesday, reinstating approximately 450 employees previously laid off under the Trump administration's federal workforce reduction... 
    Via Benzinga
    Topics Government Workforce
    News headline image
    Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial ↗
    Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 and older. 
    Via Benzinga
    News headline image
    Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
    Via ACCESS Newswire
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance ↗
    The American Pharmacists Association announced Monday it will withhold endorsement of the CDC's updated immunization schedule. 
    Via Benzinga
    News headline image
    Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading ↗
    A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks. 
    Via Benzinga
    News headline image
    Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines? ↗
    Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust." 
    Via Stocktwits
    Topics Government
    News headline image
    Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. ↗
    A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition. 
    Via Investor's Business Daily
    Topics Government
    News headline image
    DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know
    A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor Statistics report revealed a resilient labor market with non-farm payrolls rising by 139,000... 
    Via StockStory
    Topics Economy
    News headline image
    What's going on in today's session: S&P500 movers ↗
    Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session. 
    Via Chartmill
    News headline image
    Friday's session: top gainers and losers in the S&P500 index ↗
    Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
    Via Chartmill
    News headline image
    RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts ↗
    U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health... 
    Via Benzinga
    News headline image
    Thursday's session: top gainers and losers in the S&P500 index ↗
    Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
    Via Chartmill
    News headline image
    Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case ↗
    The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax. 
    Via Benzinga
    Topics Intellectual Property
    News headline image
    Gapping S&P500 stocks in Thursday's session ↗
    Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index. 
    Via Chartmill
    News headline image
    9 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    These S&P500 stocks are moving in today's session ↗
    Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
    Via Chartmill
    News headline image
    Moderna Stock Is Trading Higher Monday: What's Going On? ↗
    Moderna, Inc. (NASDAQ:MRNA) shares are trading higher Monday after the company announced its new COVID-19 vaccine secured clearance from the U.S. Food and Drug Administration (FDA) for seniors and... 
    Via Benzinga
    News headline image
    Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals ↗
    Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved efficacy and safety profile. 
    Via Benzinga
    News headline image
    These S&P500 stocks are moving in today's pre-market session ↗
    The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
    Via Chartmill
    News headline image
    Moderna’s New COVID Vaccine Gets FDA Green Light; Yet Retail Stays Cautious ↗
    Investor sentiment on Moderna turned bearish over the weekend despite FDA approval of its new COVID-19 vaccine, mNEXSPIKE, which showed higher efficacy and a favorable safety profile. 
    Via Stocktwits
    < Previous 1 2
    ...
    18 19 20 21 22 23 24 25 26
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.